Matinas BioPharma Holdings (MTNB) Return on Assets [ROA] (2014 - 2026)
Matinas BioPharma Holdings (MTNB) reported Return on Assets [ROA] of -143.61% for Q2 2026, down 1.81 percentage points from -141.80% a year earlier and down 37.36 percentage points from the prior quarter.
Powered by 
Analysis
Matinas BioPharma Holdings (MTNB) Return on Assets [ROA] (2014 - 2026) Analysis & Trends
For FY2025, Matinas BioPharma Holdings posted Return on Assets [ROA] of -104.24%, up 24.26 percentage points from FY2024.
- Return on Assets [ROA] has a five-year change of -60.70 percentage points (FY2020 to FY2025).
- By year, Return on Assets [ROA] came in at -128.50% in FY2024 (-62.88 pp), -65.62% in FY2023 (-19.29 pp), -46.33% in FY2022 (-8.94 pp) and -37.39% in FY2021 (+6.14 pp).
- The Q2 2026 figure ranks as the lowest quarterly Return on Assets [ROA] since Q1 2025.
- Year over year, Return on Assets [ROA] gained in two of the last eight quarters, with an average year-over-year change of -10.95 percentage points.
- The high point for year-over-year Return on Assets [ROA] in five years was Q4 2025 (a gain of 65.71 percentage points); the low point was Q4 2024 (a drop of 61.47 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at -106.25% (Q1 2026), -82.35% (Q4 2025) and -130.96% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 20.64% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 10.47% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 4.65% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 2.45% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 28.37% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 9.10% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 9.29% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -6.13% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 2.14% |
| 10 | Matinas BioPharma Holdings | 16.72 Mn | 4.13 Mn | - | -143.61% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -143.61% |
| Mar 31, 2026 | -106.25% |
| Dec 31, 2025 | -82.35% |
| Sep 30, 2025 | -130.96% |
| Jun 30, 2025 | -141.80% |
| Mar 31, 2025 | -167.25% |
| Dec 31, 2024 | -148.06% |
| Sep 30, 2024 | -97.94% |
| Jun 30, 2024 | -108.07% |
| Mar 31, 2024 | -107.72% |
| Dec 31, 2023 | -86.59% |
| Sep 30, 2023 | -73.21% |
| Jun 30, 2023 | -62.77% |
| Mar 31, 2023 | -54.05% |
| Dec 31, 2022 | -53.24% |
| Sep 30, 2022 | -51.67% |
| Jun 30, 2022 | -50.35% |
| Mar 31, 2022 | -44.58% |
| Dec 31, 2021 | -38.55% |
| Sep 30, 2021 | -35.79% |
API Access
Matinas BioPharma Holdings Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=MTNB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "MTNB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=MTNB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();